Sandbox: malabsorption: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 90: Line 90:
* [[IgA]] endomysial antibody
* [[IgA]] endomysial antibody
* [[IgA]] tissue transglutaminase antibody
* [[IgA]] tissue transglutaminase antibody
|-
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Childhood
Adult
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Digital clubbing]]
* Abnormal [[breathing sounds]]
* [[Cyanosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Positive [[DNA]] analysis for [[CFTR]]
* Evaluated [[nasal]] transepithelial potential difference (NPD)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Diabetes]]
* Recurrent upper and lower [[respiratory tract infections]]
* [[Infertility]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Mutations in the [[cystic fibrosis transmembrane conductance regulator]] ([[CFTR]]) protein
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L
|-
|-
! align="center" style="background:#DCDCDC;" |[[Crohns disease]]
! align="center" style="background:#DCDCDC;" |[[Crohns disease]]
Line 177: Line 150:
* Elevated [[VIP]] levels
* Elevated [[VIP]] levels
* Followed by imaging
* Followed by imaging
|-
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Childhood
Adult
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Digital clubbing]]
* Abnormal [[breathing sounds]]
* [[Cyanosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Positive [[DNA]] analysis for [[CFTR]]
* Evaluated [[nasal]] transepithelial potential difference (NPD)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Diabetes]]
* Recurrent upper and lower [[respiratory tract infections]]
* [[Infertility]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Mutations in the [[cystic fibrosis transmembrane conductance regulator]] ([[CFTR]]) protein
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L
|-
|-
! align="center" style="background:#DCDCDC;" |[[Zollinger-Ellison syndrome]]
! align="center" style="background:#DCDCDC;" |[[Zollinger-Ellison syndrome]]

Revision as of 15:45, 12 November 2017

Abbreviations: WBC: White blood cells; Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A

Cause Peak age of onset History Physical exam Lab findings Additional findings Cause/Pathogenesis Gold standard diagnosis
Fever Abdominal pain Diarrhea Weight loss
Watery Fatty WBC Hgb Plt Other lab findings
Whipple's disease 40-60 ± + + + + ↓/↑
Celiac disease Childhood

Adult

- + ± ± + - -
  • IgA endomysial antibody
  • Anti-tissue transglutaminase antibody
  • Anti-gliadin antibody
  • IgA endomysial antibody
  • IgA tissue transglutaminase antibody
Crohns disease Young adults

(20th)

+ + + + +
  • Abnormal immune response to self antigens
VIPoma 30-50 - + + + + - - -
  • Primary secretory tumor
  • Elevated VIP levels
  • Followed by imaging
Cystic fibrosis Childhood

Adult

± + - + + - -
  • Positive DNA analysis for CFTR
  • Evaluated nasal transepithelial potential difference (NPD)
Zollinger-Ellison syndrome 20-50 - + + + + - -
  • Elevated basal or stimulated serum gastrin> 120 pg/mL
Eosinophilic gastroenteritis  30th - + + + + - -
Primary bile acid malabsorption Childhood Adult - + + + + - -
Abetalipoproteinemia Infancy

Adult

- + + + + - - -
Microscopic colitis 50-70 - + + - + - -
Hyperthyroidism Any age ± + + - + - - -
  • Elevated T4
  • Elevated T3
  • Decreased TSH
Lactose intolerance Any age - + + - - - - -
Irritable bowel syndrome 30-50 - ± ± ± - - - -
  • Diagnosis of exclusion